Floatz logo

Plavix

Vascular Diseases

The Second Hospital of Anhui Medical UniversityN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Vascular Diseases cohort.

Asset / SponsorPhaseRating
Dolutegravir
Augusta University
Phase 4BB
Acetylsalicylic Acid
The Second Hospital of Anhui Medical University
Phase 4BB
3-N-BUTYLPHTHALIDE
Qianfoshan Hospital
Phase 4BB
Telcagepant
Merck Sharp & Dohme LLC
Phase 3B
FLUOXETINE
University Health Network, Toronto
Phase 2B

View all 16 →

Same molecule, other indications

Plavix is also rated in:

myocardial infarctionDormant
A
Indicative ·
81 / 100
View asset →
transient ischemic attackDormant
BBB
Indicative ·
77 / 100
View asset →
peripheral arterial diseaseDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →